CD8A and neoplasm: More recent studies by a retrospective cohort study suggest that the imbalance between cytotoxic and regulatory T lymphocytes(CD8+/Foxp3 T lymphocyte ratio) in the peri-tumoral PTC/HT(-) may affect the tumor-specific immune response.